Skip to main content

Advertisement

SpringerLink
Log in

Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy

  • Original Paper
  • Published:
Urolithiasis Aims and scope Submit manuscript

Abstract

The objective of this study is to evaluate the effects of solifenacin on double-J stent-related symptoms following uncomplicated ureterosocpic lithotripsy (URSL). A total of 70 patients who underwent double-J ureteral stent insertion following URSL were consecutively recruited and received solifenacin postoperatively. Another 70 age- and sex-matched subjects without solifenacin therapy were enrolled as a control group. The clinical data including stone and stent characteristics were collected. All subjects completed the brief-form Ureteral Symptom Score Questionnaire (Chinese-version) to assess the lower urinary tract symptoms, stent-related body pain and hematuria 2 weeks after operation. The severity of stent-related symptoms was compared between two groups. The mean age was 53.8 in solifenacin group and 53.4 years in the control group (p = 0.87). The stone characteristics, stent size, position and curl completeness were similar in both groups. Compared to the control group, solifenacin group had significantly lower total symptom score, urgency and urge incontinence scores. As for stent-related body pain, solifenacin group had significantly less flank, abdominal, urethral pain and hematuria scores (all p < 0.05). The solifenacin versus control group showed significant benefits in lower urinary tract symptoms, stent-related pain and hematuria in both genders (all p < 0.05). Four subjects encountered minor adverse events (5.7 %) and one had urinary retention (1.4 %) in solifenacin group. For patients undergoing URSL and double-J stent indwelling, postoperative solifenacin use was effective and well-tolerated for the treatment of lower urinary tract symptoms, stent-related body pain and hematuria irrespective of genders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169:1065–1069 (discussion 1069)

    Article  PubMed  CAS  Google Scholar 

  2. Sighinolfi MC, Micali S, De Stefani S, Mofferdin A, Grande M, Giacometti M, Ferrari N, Rivalta M, Bianchi G (2007) Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol 178:229–231

    Article  PubMed  CAS  Google Scholar 

  3. Damiano R, Autorino R, De Sio M, Cantiello F, Quarto G, Perdona S, Sacco R, D’Armiento M (2005) Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 48:673–678

    Article  PubMed  Google Scholar 

  4. Thomas R (1993) Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol 7:137–140

    Article  PubMed  CAS  Google Scholar 

  5. Park SC, Jung SW, Lee JW, Rim JS (2009) The effects of tolterodine extended release and alfuzosin for the treatment of double-J stent-related symptoms. J Endourol 23:1913–1917

    Article  PubMed  Google Scholar 

  6. Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D’Armiento M (2008) Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22:651–656

    Article  PubMed  Google Scholar 

  7. Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181:170–176

    Article  PubMed  Google Scholar 

  8. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P (2011) Is there a role for alpha-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol 186:928–934

    Article  PubMed  CAS  Google Scholar 

  9. Vardy MD, Mitcheson HD, Samuels TA, Wegenke JD, Forero-Schwanhaeuser S, Marshall TS, He W (2009) Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT—a double-blind, placebo-controlled trial. Int J Clin Pract 63:1702–1714

    Article  PubMed  CAS  Google Scholar 

  10. Ho CH, Chang TC, Lin HH, Liu SP, Huang KH, Yu HJ (2010) Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms. J Formos Med Assoc 109:702–708

    Article  PubMed  CAS  Google Scholar 

  11. Lim KT, Kim YT, Lee TY, Park SY (2011) Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 52:485–488

    Article  PubMed  Google Scholar 

  12. Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG (2003) Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169:1060–1064

    Article  PubMed  CAS  Google Scholar 

  13. Gunlusoy B, Degirmenci T, Arslan M, Kozacyoglu Z, Minareci S, Ayder AR (2008) Is ureteral catheterization necessary after ureteroscopic lithotripsy for uncomplicated upper ureteral stones? J Endourol 22:1645–1648

    Article  PubMed  Google Scholar 

  14. Chen YT, Chen J, Wong WY, Yang SS, Hsieh CH, Wang CC (2002) Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial. J Urol 167:1977–1980

    Article  PubMed  Google Scholar 

  15. Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM (2006) Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 67:35–39

    Article  PubMed  Google Scholar 

  16. Gupta M, Patel T, Xavier K, Maruffo F, Lehman D, Walsh R, Landman J (2010) Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. J Urol 183:598–602

    Article  PubMed  CAS  Google Scholar 

  17. Joshi HB, Chitale SV, Nagarajan M, Irving SO, Browning AJ, Biyani CS, Burgess NA (2005) A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol 174:2303–2306

    Article  PubMed  CAS  Google Scholar 

  18. Candela JV, Bellman GC (1997) Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol 11:45–47

    Article  PubMed  CAS  Google Scholar 

  19. Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J (2005) A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 48:464–470

    Article  PubMed  CAS  Google Scholar 

  20. Herschorn S, Stothers L, Carlson K et al (2010) Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial. J Urol 183:1892–1898

    Article  PubMed  CAS  Google Scholar 

  21. van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183

    Article  PubMed  Google Scholar 

  22. Osman Y, El-Tabey N, Refai H, Elnahas A, Shoma A, Eraky I, Kenawy M, El-Kapany H (2008) Detection of residual stones after percutaneous nephrolithotomy: role of nonenhanced spiral computerized tomography. J Urol 179:198–200 discussion 200

    Article  PubMed  Google Scholar 

  23. Park J, Hong B, Park T, Park HK (2007) Effectiveness of noncontrast computed tomography in evaluation of residual stones after percutaneous nephrolithotomy. J Endourol 21:684–687

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that they have no conflict of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending).

Author information

Authors and Affiliations

  1. Department of Urology, National Taiwan University Hospital, and National Taiwan University College of Medicine, Taipei, Taiwan

    Yuan-Ju Lee, Kuo-How Huang, Hung-Ju Yang, Hong-Chiang Chang, Jun Chen & Teng-Kai Yang

  2. Division of Urology, Department of Surgery, Cardinal Tien Hospital, Yonghe Branch, and School of Medicine, Fu Jen Catholic University, No. 80, Zhongxing Street, Yonghe Dist., New Taipei City, 23445, Taiwan

    Hung-Ju Yang & Teng-Kai Yang

Authors
  1. Yuan-Ju Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kuo-How Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hung-Ju Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong-Chiang Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Teng-Kai Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Teng-Kai Yang.

Additional information

Y.-J. Lee and K.-H. Huang have equal contributions.

Appendix

Appendix

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, YJ., Huang, KH., Yang, HJ. et al. Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis 41, 247–252 (2013). https://doi.org/10.1007/s00240-013-0554-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-013-0554-y

Keywords

Search

Navigation